DNA damage repair molecules
Ideaya Secures $400M Deal for Biocytogen Bispecific ADC, Aiming to Enhance Drug Combinations
Ideaya Biosciences, Biocytogen, bispecific ADC, drug combinations, $400M deal, biobucks, DNA damage repair molecules
Actionable Insights Powered by AI
Ideaya Biosciences, Biocytogen, bispecific ADC, drug combinations, $400M deal, biobucks, DNA damage repair molecules